Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

NCT ID: NCT06170775

Last Updated: 2023-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-20

Study Completion Date

2025-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulp Disease, Dental

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sodiumhexametaphosphate

Group Type EXPERIMENTAL

Pulp therapy

Intervention Type OTHER

Pulp capping material

Sodiumhexametaphosphate

Intervention Type DRUG

Sodiumhexametaphosphate

MTA

Group Type ACTIVE_COMPARATOR

Pulp therapy

Intervention Type OTHER

Pulp capping material

MTA

Intervention Type OTHER

MTA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pulp therapy

Pulp capping material

Intervention Type OTHER

Sodiumhexametaphosphate

Sodiumhexametaphosphate

Intervention Type DRUG

MTA

MTA

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* physical healthy children
* cooperative children
* primary molar with deep carious lesion
* absence of pain or transient momentary pain

Exclusion Criteria

* Uncooperative children
* children with systemic disorders
* periapical lesions
* sever pain
Minimum Eligible Age

4 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Ahmed Mahmoud

Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1290

Identifier Type: -

Identifier Source: org_study_id